Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience

被引：1
|
作者：
Guo, Tian-Jiao [1 ,2 ,3 ]
Huang, Xiao-Jun [1 ,2 ]
Wen, Lei [1 ,2 ]
Lu, Jin [1 ,2 ]
机构：
[1] Peking Univ, Dept Hematol, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Peking Univ, Inst Hematol, 11 Xizhimen South St, Beijing 100044, Peoples R China
[3] Capital Med Univ, Fu Xing Hosp, Dept Hematol, Beijing 100038, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2017年 / 130卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Bortezomib; Multiple Myeloma; Secondary Primary Malignancies; STEM-CELL TRANSPLANTATION;
D O I：
10.4103/0366-6999.198017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：239 / 241
页数：3
相关论文
共 50 条
  • [1] Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
    Tian-Jiao Guo
    Xiao-Jun Huang
    Lei Wen
    Jin Lu
    中华医学杂志英文版, 2017, 130 (02) : 239 - 241
  • [2] Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature
    Badros, Ashraf
    Goloubeva, Olga
    Dalai, Jay S.
    Can, Llyas
    Thompson, Jennifer
    Rapoport, Aaron P.
    Heyman, Meyer
    Akpek, Gorgon
    Fenton, Robert G.
    CANCER, 2007, 110 (05) : 1042 - 1049
  • [3] The risk of secondary primary malignancies after therapy for multiple myeloma
    Areethamsirikul, Nuchanan
    Reece, Donna E.
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3012 - 3021
  • [4] Secondary primary malignancies in patients with multiple myeloma: A single institution experience
    Fei, Fei
    Reddy, Vishnu
    Rosenblum, Frida
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (05) : 674 - 679
  • [5] Neurotoxicity of bortezomib therapy in multiple myeloma (MM): A single center experience.
    Badros, Ashraf
    Dalal, Jay S.
    Goloubeva, Olga
    Thompson, Jenni
    Yager, Kelly
    Ilyas, Can
    Rapoport, Aaron P.
    Fenton, Robert G.
    Akpek, Gorgun
    Yanovich, Saul
    Sausville, Edward
    BLOOD, 2006, 108 (11) : 1008A - 1008A
  • [6] Bortezomib as front line therapy in advanced multiple myeloma: A single center experience
    Mazza, P.
    Specchia, M. R.
    Casulli, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 234 - 234
  • [7] Multiple primary malignancies involving lung cancer: a single-center experience
    Ventura, Luigi
    Carbognani, Paolo
    Gnetti, Letizia
    Rossi, Maurizio
    Tiseo, Marcello
    Silini, Enrico Maria
    Sverzellati, Nicola
    Silva, Mario
    Succi, Marcello
    Braggio, Cesare
    Cattadori, Sara
    Bocchialini, Giovanni
    Balestra, Valeria
    Rusca, Michele
    Ampollini, Luca
    TUMORI JOURNAL, 2021, 107 (03): : 196 - 203
  • [8] Bortezomib in relapsed/refractory myeloma patients: A single-center experience
    Grasso, M.
    Tavera, S.
    Bonferroni, M.
    Calvi, R.
    Rapezzi, D.
    Gallamini, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 149 - 150
  • [9] Anti-BCMA therapy in multiple myeloma: a single-center experience
    Puertas, Borja
    Fernandez, Adolfo
    Jara, Mirian
    Hernandez, Alberto
    Gomez, Sandra
    Alejo, Elena
    Alonso, David
    Maria Navarro, Jose
    Rey, Bea
    Fonseca, Marta
    Avendano, Alejandro
    Baile, Monica
    Cabero, Almudena
    Cabrero, Monica
    Lopez, Miriam
    Perez, Estefania
    Martin, Ana
    Lopez, Lucia
    Puig, Noemi
    Gonzalez, Veronica
    Mateos, Maria-Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S96 - S97
  • [10] Anti-BCMA Therapy in Multiple Myeloma: A Single-Center Experience
    Puertas, Borja
    Fernandez, Adolfo
    Jara, Mirian
    Hernandez, Alberto
    Gomez, Sandra
    Alejo, Elena
    Maria Navarro, Jose
    Alonso, David
    Fonseca, Marta
    Rey, Beatriz
    Avendano, Alejandro
    Baile, Monica
    Cabero, Almudena
    Cabrero, Monica
    Lopez, Miriam
    Perez, Estefania
    Martin, Ana
    Lopez, Lucia
    Puig, Noemi
    Gonzalez-Calle, Veronica
    Victoria Mateos, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S413 - S413
12345